论文部分内容阅读
本文报告105例流行性出血热早期患者,随机分为治疗组与对照组,治疗组应用广谱抗病毒药物病毒唑治疗,对照组为对症治疗,结果发现治疗组较对照组退热和尿蛋白消失时间明显缩短,同时越过低血压休克期和少尿期者明显增加,且特异性循环免疫复合物消失比对照组快。说明抗病毒药物—病毒唑治疗流行性出血热早期患者是有效的。
This article reports 105 cases of early patients with epidemic hemorrhagic fever were randomly divided into treatment group and control group, the treatment group with broad-spectrum antiviral ribavirin treatment, the control group was symptomatic treatment and found that the treatment group than the control group antipyretics and urinary protein Disappear time was significantly shortened, while over the hypotensive shock and oliguria were significantly increased, and disappearance of specific circulating immune complexes faster than the control group. This shows that antiviral drug-ribavirin is effective in treating early-stage patients with epidemic hemorrhagic fever.